Discover the PCG Difference!

PCG Clinical Service News
BackNovember 23, Uppsala, Sweden

PCG Clinical Services Small Biotech event

PCG Clinical Services Small Biotech event

What clinical trials do small biotech companies

need to perform, to get to proof of concept?

Join us for our free lunch & seminar November 23rd. We are bringing together our experts in clinical drug development for a half day of learning. If you are a small biotech company and would like to learn more about how to navigate the transition from pre-clinical to clinical research & development, please register below. Reducing time to market and increasing the chances of a drug’s success are essential for pharmaceutical companies of all sizes, but especially small biotechs that may not have access to extensive capital. Asking the right questions is essential for small biotech companies approaching the clinical phase, that's why our experts will address the whos, whats, where, whens, and hows of clinical research. Register below before our limited seating runs out.

Registration closed

When:
November 23rd, 2017

Time:
11:30 to 18:00

Where:
PCG Clinical Services Office:
Kungsängsvägen 19,

Uppsala 753 23
Sweden

Agenda:

  • Registration and lunch
  • Intro by Antonio Mastroianni
  • TPP Driven Drug Development by Sven Undeland
  • Regulatory Overview by Gunnar Danielsson
  • // Break
  • Clinical Design considerations by Gunnar Danielsson
  • eSource and Viedoc by Sverre Bengtsson
  • Panel Discussion with all 4, moderated by Antonio Mastroianni
  • Conclusion by Sverre Bengtsson
  • Mingle, drinks, Glögg

Learn about our excellent speaker line up:

Gunnar Danielsson

Gunnar Danielsson Sr. Regulatory Advisor

Gunnar has a BSc in Natural Science and almost 40 years’ experience in Clinical Research. Gunnar served as a renowned GCP Inspector for the Swedish MPA for over 10 years, and has a wealth of experience from the Pharmaceutical industry in terms of quality management, electronic systems, data management, and clinical design and conduct. Gunnar is a key advisory resource and he helps to design studies in the most effective way, meeting regulatory requirements.

Sverre Bengtson

Sverre Bengtsson Co-founder, Sr. VP, Strategic Relations, Chairman of the Board for the PCG group of companies.
Sverre Bengtsson is one of our Co-founders and has served as a member of our board of directors since our inception in March 2003. Sverre holds an MBA from the University of Gothenburg, Sweden, and has more than 20 years of experience in clinical research.

Sven Undeland

Sven Undeland,owner at FHC Undeland and partner at PCG Clinical Services
Sven has a broad commercial and clinical development experience from international pharmaceutical industry, based on leading positions in Pharmacia, AstraZeneca and Orexo. Sven’s strength is to give strategic commercial support in life science projects during development, to prepare the projects for successful licensing or launch. In addition, Sven has five years’ experience from business development and has successfully negotiated and completed several licensing deals. Sven has a Master in Science (M.Sc) in Chemical and Administrative Sciences.

Antonio Mastroianni

Antonio Mastroianni, Business Developer at PCG Clinical Services
Antonio has 20 years of multi-sector experience in government, non-profit, standard-setting bodies, and for-profit organizations. Over the course of working with various organizations across the US and Europe Antonio has specialized in IT/Telecom management consulting and Healthcare. His primary focus today with PCG Clinical Service is in partnership management, business development, and transformation.

This will be an small gathering so register while there are seats available.